A continuous-flow DBD plasma reactor was used for carbamazepine degradation in an aqueous solution, with >90% degradation achieved under optimal conditions, surpassing UV-based AOPs in efficiency and energy cost.
No takes yet. Share an insight, caveat, or question.
Babalola et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: